Winstanley Enterprises is a leading commercial real estate developer based in Concord, MA, specializing in the acquisition and development of properties across various asset classes, including industrial, life science, retail, office, and multi-family. With a portfolio comprising over 125 properties and 20 million square feet, Winstanley has a proven track record of providing significant capital appreciation for institutional and equity investors through their competitive edge in property acquisition and repositioning.
Known for their unique approach, Winstanley focuses on delivering high-quality, cost-effective services to tenants, operating and maintaining properties to the highest standards. Their successful projects include the development of 100 College Street, a pioneering $200 million life-science building in New Haven, which now serves as the worldwide headquarters for Alexion Pharmaceuticals, and the ongoing development of 101 College Street, a state-of-the-art life-science building. Additionally, Winstanley has established a strong presence in the logistics sector, becoming one of the largest warehouse landlords in New England, and has transformed Page Field Commons into Southwest Florida's dominant power center through strategic tenant partnerships and property enhancements.
Generated from the website